Parkside Financial Bank & Trust Biotechnology

Parkside Financial Bank & Trust

$772 Million
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ABSI Absci Corp	$248M	$0 0.0% of portfolio	250	Q3 2024 New
ADPT Adaptive Biotechnologies Corp	$1.7B	$0 0.0% of portfolio	85	Q1 2025 New
AGIO Agios Pharmaceuticals, Inc.	$2.14B	$0 0.0% of portfolio	30	Q1 2025 New
ALLO Allogene Therapeutics, Inc.	$174M	$0 0.0% of portfolio	444	Q1 2025 Added 179.25%
FOLD Amicus Therapeutics, Inc.	$1.8B	$0 0.0% of portfolio	110	Q1 2025 New
AVXL Anavex Life Sciences Corp.	$779M	$0 0.0% of portfolio	60	Q1 2025 New
ANNX Annexon, Inc.	$131M	$0 0.0% of portfolio	140	Q1 2025 New
APLS Apellis Pharmaceuticals, Inc.	$2.11B	$0 0.0% of portfolio	5	Q1 2025 Reduced 82.76%
ARDX Ardelyx, Inc.	$693M	$0 0.0% of portfolio	110	Q1 2025 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	45	Q1 2025 New
ARVN Arvinas, Inc.	$438M	$0 0.0% of portfolio	30	Q1 2025 New
BEAM Beam Therapeutics Inc.	$1.51B	$0 0.0% of portfolio	20	Q1 2025 New
BCRX Biocryst Pharmaceuticals Inc	$1.68B	$0 0.0% of portfolio	70	Q1 2025 New
CAPR Capricor Therapeutics, Inc.	$249M	$0 0.0% of portfolio	40	Q1 2025 New
CLDX Celldex Therapeutics, Inc.	$1.05B	$0 0.0% of portfolio	40	Q1 2025 New
CDXS Codexis, Inc.	$169M	$0 0.0% of portfolio	115	Q1 2025 New
COGT Cogent Biosciences, Inc.	$615M	$0 0.0% of portfolio	65	Q1 2025 New
CRMD Cor Medix Inc.	$465M	$0 0.0% of portfolio	65	Q1 2025 New
DAWN Day One Biopharmaceuticals, Inc.	$514M	$0 0.0% of portfolio	40	Q1 2025 New
DYN Dyne Therapeutics, Inc.	$423M	$0 0.0% of portfolio	80	Q1 2025 New
EWTX Edgewise Therapeutics, Inc.	$797M	$0 0.0% of portfolio	40	Q1 2025 New
TRDA Entrada Therapeutics, Inc.	$237M	$0 0.0% of portfolio	40	Q1 2025 New
ERAS Erasca, Inc.	$173M	$0 0.0% of portfolio	285	Q1 2025 New
EYPT Eye Point Pharmaceuticals, Inc.	$336M	$0 0.0% of portfolio	70	Q1 2025 New
HRMY Harmony Biosciences Holdings, Inc.	$2.03B	$0 0.0% of portfolio	27	Q1 2025 Added 125.0%
HLVX Hille Vax, Inc.	$68.9M	$0 0.0% of portfolio	285	Q1 2025 New
HUMA Humacyte, Inc.	$249M	$0 0.0% of portfolio	120	Q1 2025 New
IDYA Ideaya Biosciences, Inc.	$1.02B	$0 0.0% of portfolio	60	Q1 2025 New
IBRX Immunity Bio, Inc.	$1.12B	$0 0.0% of portfolio	175	Q1 2025 New
NTLA Intellia Therapeutics, Inc.	$922M	$0 0.0% of portfolio	100	Q1 2025 New
IOVA Iovance Biotherapeutics, Inc.	$314M	$0 0.0% of portfolio	120	Q1 2025 New
KROS Keros Therapeutics, Inc.	$345M	$0 0.0% of portfolio	55	Q1 2025 New
LTRN Lantern Pharma Inc.	$38.8M	$0 0.0% of portfolio	260	Q3 2024 New
LQDA Liquidia Corp	$801M	$0 0.0% of portfolio	50	Q1 2025 New
MNKD Mannkind Corp	$983M	$0 0.0% of portfolio	170	Q1 2025 New
MRVI Maravai Lifesciences Holdings, Inc.	$363M	$0 0.0% of portfolio	95	Q1 2025 New
MIRM Mirum Pharmaceuticals, Inc.	$1.85B	$0 0.0% of portfolio	15	Q1 2025 New
GLUE Monte Rosa Therapeutics, Inc.	$232M	$0 0.0% of portfolio	95	Q1 2025 New
CDXC Chroma Dex Corp.	$420M	$0 0.0% of portfolio	95	Q1 2025 New
NVAX Novavax Inc	$551M	$0 0.0% of portfolio	60	Q1 2025 New
NUVL Nuvalent, Inc.	$3.35B	$0 0.0% of portfolio	10	Q1 2025 New
OCGN Ocugen, Inc.	$210M	$0 0.0% of portfolio	49	Q4 2022 New
ORIC Oric Pharmaceuticals, Inc.	$426M	$0 0.0% of portfolio	50	Q1 2025 New
PHAT Phathom Pharmaceuticals, Inc.	$344M	$0 0.0% of portfolio	85	Q1 2025 New
PRTA Prothena Corp Public LTD CO	$309M	$0 0.0% of portfolio	30	Q1 2025 New
RXRX Recursion Pharmaceuticals, Inc.	$1.01B	$0 0.0% of portfolio	165	Q1 2025 New
RGNX Regenxbio Inc.	$396M	$0 0.0% of portfolio	70	Q1 2025 New
RLAY Relay Therapeutics, Inc.	$458M	$0 0.0% of portfolio	125	Q1 2025 New
REPL Replimune Group, Inc.	$512M	$0 0.0% of portfolio	45	Q1 2025 New
RCKT Rocket Pharmaceuticals, Inc.	$242M	$0 0.0% of portfolio	110	Q1 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.